Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

23,796 total articles

Enovis to Participate in the 2026 Wells Fargo Healthcare Conference

Enovis to Participate in the 2026 Wells Fargo Healthcare Conference

Enovis Corporation announced its participation in the 2026 Wells Fargo HealthCare conference with its CEO and CFO leading a fireside chat. The event will be webcast live and replayed on the company's website. Enovis is a medical technology company focused on developing clinically differentiated solutions to improve patient outcomes and operational …

Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer

Lifeward Appoints Josh Hexter Interim Chief Executive Officer and Rami Aviram Chief Financial Officer

Lifeward Ltd. has appointed Josh Hexter as Interim CEO and Rami Aviram as CFO, marking a leadership transition following promising commercial momentum. The company reported 16% year-over-year revenue growth in Q2 2026, driven by increases in sales of its ReWalk® Personal Exoskeleton and AlterG® products. Lifeward intends to leverage its established…

Cal-Maine Foods Releases Fiscal Year 2025 Impact Report

Cal-Maine Foods Releases Fiscal Year 2025 Impact Report

Cal-Maine Foods, the largest U.S. egg producer, released its Fiscal Year 2025 Impact Report under a new framework. The report details the company's strategy to expand its egg and egg-based food platform through investments in operations, people, sustainability, and acquisitions. Highlights include workforce growth, charitable contributions, environ…

Postal Realty Achieves BBB Investment Grade Rating from Fitch Ratings

Postal Realty Achieves BBB Investment Grade Rating from Fitch Ratings

Postal Realty Trust, Inc. has received a BBB investment grade credit rating with a stable outlook from Fitch Ratings. This rating acknowledges the company's predictable cash flows, strong portfolio leased primarily to the USPS, and conservative capital structure. The rating also applies to the company's senior unsecured revolving credit facility an…

YY Group Enters New Era as YYForce, Expanding AI, Automation and Human-Robot Workforce Strategy; Nasdaq Ticker Changes to “YFOR”

YY Group Enters New Era as YYForce, Expanding AI, Automation and Human-Robot Workforce Strategy; Nasdaq Ticker Changes to “YFOR”

YY Group Holding Limited, an AI-enabled workforce management and integrated facility management provider, announced its corporate rebranding to YYForce Inc. and a Nasdaq ticker change from YYGH to YFOR effective September 2, 2026. The rebranding reflects the company’s evolution into a global AI and automation platform serving various industries. Op…

Teva and Trump Administration Announce Intent to Reach Agreement around Affordable Medicines and Supply Chain Security for Patients in the U.S.

Teva and Trump Administration Announce Intent to Reach Agreement around Affordable Medicines and Supply Chain Security for Patients in the U.S.

Teva Pharmaceutical Industries Ltd. announced a collaborative intent with the Trump Administration to reduce the prices of select medicines for Medicaid-covered patients in the U.S., while supporting continued investment in scientific innovation and domestic pharmaceutical manufacturing. The agreement aims to align Medicaid pricing with prices in l…

Avista Makes Annual Price Adjustment Requests in Washington

Avista Makes Annual Price Adjustment Requests in Washington

Avista Corporation has filed for annual rate adjustments in Washington State, proposing an approximate 11.5% reduction in natural gas rates and a nearly unchanged electric rate. If approved by the Washington Utilities and Transportation Commission, these adjustments would lower monthly natural gas bills for residential customers by about $7.38 this…

ARRAY Technologies Completes Acquisition of Affordable Wire Management, Expanding Balance-of-System Strategy

ARRAY Technologies Completes Acquisition of Affordable Wire Management, Expanding Balance-of-System Strategy

ARRAY Technologies has completed the acquisition of Affordable Wire Management (AWM), a provider of wire management and balance-of-system solutions for utility-scale solar and energy storage projects. This strategic move broadens ARRAY's product portfolio, enhances its service capabilities for solar and distributed generation customers, and opens n…

Clover Health to Participate in Upcoming Investor Conferences

Clover Health to Participate in Upcoming Investor Conferences

Clover Health Investments, Corp., a Medicare-focused physician enablement technology company, announced that its Interim CFO Clay Thornton will present at the Jefferies Healthcare Services and Technology Conference and participate in the Deutsche Bank Healthcare Summit in September 2026. The company continues to highlight its software platform Clov…

Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation

Kyntra Bio Continues Balance Sheet Transformation with Material Reduction of Royalty Financing Obligation

Kyntra Bio announced a significant amendment to its royalty financing agreement, reducing its maximum payment obligation from $125 million to $65 million through an accelerated $42.6 million upfront payment and a capped revenue-sharing arrangement. Alongside settling bankruptcy obligations of its European subsidiary, these actions have significantl…

SL Green Realty Corp. to Release Third Quarter 2026 Financial Results After Market Close on October 21, 2026

SL Green Realty Corp. to Release Third Quarter 2026 Financial Results After Market Close on October 21, 2026

SL Green Realty Corp., the largest office landlord in Manhattan, will release its third quarter 2026 financial results after market close on October 21, 2026. The company's executive management, led by CEO Marc Holliday, will discuss the results in a conference call and webcast on October 22, 2026. Supplemental financial data will be provided on th…

Oxbridge Re to Attend Rendez-Vous de Septembre in Monte-Carlo as Company Advances Reinsurance, Tokenization and AI Infrastructure Strategy

Oxbridge Re to Attend Rendez-Vous de Septembre in Monte-Carlo as Company Advances Reinsurance, Tokenization and AI Infrastructure Strategy

Oxbridge Re Holdings Limited will attend the Rendez-Vous de Septembre in Monte-Carlo to engage stakeholders as it expands its reinsurance business and SurancePlus tokenization platform. In 2026, SurancePlus completed five tokenized reinsurance securities offerings leveraging blockchain technology, linking traditional reinsurance markets with digita…

SciSparc: Subsidiary NeuroThera Labs Achieves Significant Enrollment Momentum in SCI‑210 Autism Clinical Trial

SciSparc: Subsidiary NeuroThera Labs Achieves Significant Enrollment Momentum in SCI‑210 Autism Clinical Trial

SciSparc Ltd. announced significant progress in participant enrollment for NeuroThera Labs' clinical trial testing SCI-210, a novel CBD and CannAmide™ combination treatment for autism spectrum disorder symptoms. The double-blind study at Soroka Medical Center aims to enroll 60 pediatric patients, assessing SCI-210's efficacy and safety relative to …

PMV Pharma Announces Proposed Public Offering of Securities

PMV Pharma Announces Proposed Public Offering of Securities

PMV Pharmaceuticals, a precision oncology company targeting p53 mutations in cancer, has begun a proposed public offering of its common stock, pre-funded warrants, and accompanying warrants, subject to market and other conditions. The offering aims to raise capital to support the company's ongoing development programs. TD Cowen is the sole book-run…

PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial

PMV Pharmaceuticals Announces Updated Promising Rezatapopt Monotherapy Interim Ovarian Cancer Data From PYNNACLE Phase 2 Pivotal Trial

PMV Pharmaceuticals announced updated interim data from its PYNNACLE Phase 2 trial evaluating rezatapopt monotherapy in platinum-resistant/refractory ovarian cancer patients with TP53 Y220C mutations. The trial showed a 46% overall response rate with a median duration of response of 10 months. The FDA recently supported the company's plan for accel…

NorthStrive Acquisition Corp I. Announces the Separate Trading of its Class A Ordinary Shares, Rights and Warrants, Commencing September 2, 2026

NorthStrive Acquisition Corp I. Announces the Separate Trading of its Class A Ordinary Shares, Rights and Warrants, Commencing September 2, 2026

NorthStrive Acquisition Corp I., a Cayman Islands-incorporated special purpose acquisition company (SPAC), announced that starting September 2, 2026, holders of its units may elect to trade its Class A ordinary shares, rights, and warrants separately on Nasdaq under the symbols NSAI, NSAIR, and NSAIW. The company has not selected any acquisition ta…